Crossmark

Targeting XPO1 enhances innate immune response and inhibits KSHV lytic replication during primary infection by nuclear stabilization of the p62 autophagy adaptor protein

Crossref DOI link: https://doi.org/10.1038/s41419-020-03303-1

Published Online: 2021-01-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Meng, Wen

Gao, Shou-Jiang
Funding

Funding for this research was provided by:

U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA096512, CA124332, CA132637, CA213275, CA197153)

U.S. Department of Health & Human Services | NIH | National Cancer Institute

U.S. Department of Health & Human Services | NIH | National Cancer Institute

U.S. Department of Health & Human Services | NIH | National Cancer Institute

U.S. Department of Health & Human Services | NIH | National Cancer Institute

U.S. Department of Health & Human Services | NIH | National Institute of Dental and Craniofacial Research (DE025465)
License Information

Text and Data Mining valid from 2021-01-04

Version of Record valid from 2021-01-04
More Information

Article History

Received: 19 October 2020

Revised: 27 November 2020

Accepted: 2 December 2020

First Online: 4 January 2021

Conflict of interest

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below